Annual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.

Medical Molecular Morphology, published by SPRINGER JAPAN KK, stands as a significant resource in the fields of medicine and molecular biology, bridging critical insights between histological studies and modern therapeutic approaches. With an ISSN of 1860-1480 and E-ISSN of 1860-1499, this journal has evolved since its inception in 1996 and has continued to provide a platform for innovative research through 2024, establishing its relevance particularly in the realms of medical pathology and molecular morphology. Although categorized as Q3 in Medicine (miscellaneous) and Q4 in Molecular Biology per the 2023 quartiles, the journal's unique contributions cannot be understated, as evidenced by its Scopus rankings, which place it in the 52nd percentile for Pathology and 19th percentile for Molecular Biology. The journal’s mission focuses on disseminating valuable findings that enhance the understanding of cellular and molecular structures and their implications in health and disease. As access options are not currently open access, it remains essential for professionals and researchers to consider the journal's contributions as they pursue academic growth and impactful research in these dynamic fields.

ACTA HISTOCHEMICA ET CYTOCHEMICA, published by the Japan Society of Histochemistry & Cytochemistry, is a reputable journal specializing in the fields of histochemistry, cytochemistry, and related disciplines. With an ISSN of 0044-5991 and an E-ISSN of 1347-5800, this journal provides a crucial platform for researchers to disseminate their findings and advances in the study of cellular and tissue structures at a biochemical level. The journal, which has been in publication since 1968, holds a commendable position within several academic categories, achieving a Q3 ranking in Biochemistry and Cell Biology and a Q2 ranking in both Histology and Pathology and Forensic Medicine as of 2023. Its Scopus rankings further affirm its impact, particularly within the fields of Histology and Pathology. Although it does not offer open access, ACTA HISTOCHEMICA ET CYTOCHEMICA remains an essential resource for academicians, professionals, and students seeking to stay informed on the latest trends and research developments in histochemical and cytochemical processes. The journal is located at C/O Nakanishi Printing Co Ltd, Shimodachiuri-Ogawa, Kamigyo-ku, Kyoto 602-8048, Japan, making it a significant outlet for scientific communication within and beyond the Japanese research community.

MOLECULAR & CELLULAR PROTEOMICS, published by Elsevier, stands as a premier journal in the fields of Biochemistry, Analytical Chemistry, and Molecular Biology, with a distinguished Q1 ranking reflecting its high impact and contribution to the scientific community. Established in 2002, this journal has consistently provided a platform for the latest research in protein science, merging molecular biology with advanced analytical techniques. With impressive Scopus rankings—41st in Biochemistry and 16th in Analytical Chemistry—it caters to an audience of researchers, professionals, and students eager to explore cutting-edge developments in proteomics. Although currently not designated as open access, the journal aims to foster knowledge dissemination through accessible research content. As it continues to evolve until 2024, MOLECULAR & CELLULAR PROTEOMICS is essential for anyone passionately engaged in the ever-expanding field of proteomics.

Welcome to the JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, a premier platform for the dissemination of cutting-edge research in the fields of anatomy and histology. Published by SAGE PUBLICATIONS LTD, this esteemed journal has been a cornerstone of academic inquiry since its inception in 1953 and continues to play a vital role in advancing our understanding of cellular structure and function. With an impressive Impact Factor reflected in its rank as Q1 in both Anatomy and Histology categories, the journal ranks #5 out of 48 in Medicine Anatomy and #17 out of 62 in Medicine Histology, making it an essential resource for researchers and professionals alike. The journal provides a rigorous peer-review process and encourages submissions that enhance the scientific community's knowledge. As a vital resource for students, professionals, and researchers focusing on histochemical methodologies, the JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY offers insights into the latest advancements and critical debates within this dynamic discipline.

TISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.

EBioMedicine is an esteemed open-access journal published by ELSEVIER, dedicated to advancing the fields of biochemistry, genetics, and molecular biology, as well as medicine. Since its inception in 2014, EBioMedicine has established itself as a prominent platform for disseminating high-quality research, evidenced by its impressive rankings in Scopus, where it holds a Q1 category in both Biochemistry, Genetics and Molecular Biology and Medicine for 2023. With an exceptional impact factor that places it in the top percentiles (97th in Medicine and 93rd in Biochemistry), the journal is recognized for its rigorous peer-review process and its commitment to fostering scientific collaboration. Open access since its launch, EBioMedicine ensures that groundbreaking research is readily available to researchers, professionals, and students worldwide, enhancing knowledge dissemination and driving innovation in these crucial fields. For those seeking to stay at the forefront of biomedical research, EBioMedicine is an invaluable resource.

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

International Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.